4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Palatin Technologies, Inc. (PTN) operates in the Biotechnology industry and is headquartered in Monmouth Junction, United States with about 29 employees. Its market capitalization is roughly $19 million. In the fiscal year ended 2025-06-30, PTN reported $0M in revenue and ($17M) in net income.
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.
Interactive charts & full statements → Open the PTN valuation workbench →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $4M | $5M | $2M |
| Gross Profit | $0M | $4M | $4M | $1M |
| Operating Income (EBIT) | ($23M) | ($30M) | ($34M) | ($37M) |
| Net Income | ($17M) | ($30M) | ($24M) | ($36M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $4M | $0M | $9M | $0M | $0M | — |
| Gross Profit | — | — | — | $0M | $0M | $0M |
| Operating Income (EBIT) | ($2M) | ($7M) | $5M | ($5M) | ($5M) | — |
| Net Income | ($1M) | ($7M) | $5M | ($2M) | ($5M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | $3M | $11M | $18M | $36M |
| Total Liabilities | $8M | $11M | $20M | $20M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PTN viewer.
About TickerBase · Data methodology & sources